SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $28.6 million in its second quarter.
The Seattle-based company said it had a loss of 46 cents per share. Losses, adjusted for non-recurring costs, came to 40 cents per share.
The drug developer posted revenue of $28.8 million in the period.
Omeros shares have climbed roughly 2% since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.53, an increase of roughly 3% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News